The results of biochemical indicators elicited that the lymphocyte and activated partial thromboplastin time (APTT) levels of COVID‐19 patients were significantly lower than those in health cohort, while hemoglobin (HGB) and total bilirubin (TIBIL) levels were significantly higher than those in health group (Figure S2, Table S1). This evidence concerns the gene CYGB and COVID-19.